News
Patients must express PPARG in at least 60 percent of tumor cells to enroll in the trial and receive the investigational drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback